Characterization of T-cell responses against IκBα in cancer patients

Immunology and Microbiology

• T Cell 100%
• Cytotoxic T Cell 66%
• B Cell 33%
• Cytotoxic T-Cell 33%
• Proteasome 33%
• Carcinoma Cell 33%
• Light Chain 33%
• Target Cell 33%
• Tumor Cell 33%
• Enhancer Region 33%
• Granzyme B 33%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Cytotoxic T Cell 66%
• Proteasome 33%
• Enhancer Region 33%
• Light Chain 33%
• B Cell 33%
• Granzyme B 33%
• Target Cell 33%

Keyphrases

• Resistance to Therapy 50%
• Activated B Cells 50%
• Inhibitory Proteins 50%
• Nuclear Factor 50%
• Human Melanoma Cells 50%